| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.007 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.082 | 0.009 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |